Epidemiology of XXXX in Japan: Analysis of Japanese Registry of Neuroendovascular Therapy (JR-NET2).

@entity1 @entity410 @entity932 @entity2457 @entity1188 @entity2458 @entity1211
We developed the Japanese Registry of Neuroendovascular Therapy 2 (JR-NET2) database and used the information for a retrospective, nation-wide multicenter, observational study to clarify the clinical characteristics, current status of procedures, and outcome of @entity1 treated by neuroendovascular therapy in Japan. In this report, we analyzed the clinical characteristics of @entity2457 ( @entity2457 ) in the JR-NET2 database. All @entity1 with @entity2457 treated with endovascular therapy in 150 Japanese hospitals were included. @entity1 characteristics, clinical presentations, and imaging characteristics were analyzed. A total of 1,075 @entity1 with @entity2457 underwent 1,520 endovascular procedures. Of 1,075 @entity1 , 45% were @entity1 and 55% were @entity1 . The mean age was 65  13 years. The most frequent location of @entity2457 was the cavernous sinus (43.6%), followed by the @entity2458 ( @entity2458 ) (33.4%). Twelve percent of the @entity1 had @entity932 , 9% had @entity1188 , and 3% had @entity410 . The statistically significant independent risk factors of @entity932 were @entity2458 , superior sagittal sinus (SSS), tentorium, anterior cranial fossa, cranio-cervical junction, cortical @entity1211 (CVR), and varix. Risk factors of @entity1188 were age older than 60 years, male sex, @entity2458 , SSS, and CVR. Risk factors of @entity410 were male sex, SSS, and CVR. This is the largest nationwide report, to date, of the clinical characteristics of @entity2457 treated by neuroendovascular therapy. CVR was a major risk factor of aggressive symptoms.
